Skip to main content

Viral Emerging and Re-emerging Infectious Diseases

Thematic Series

New Content Item

Edited by Alfonso J. Rodriguez-Morales

​​​​​​​The world has experienced over the last decades a significant increase in the number of emerging and re-emerging outbreaks and epidemics associated to viral diseases. Just as an example, Zika and chikungunya emerged in new regions of the World, such as Latin America, where multiple new issues have raised the attention for the rest of the globe, including the concern as an international public health emergency related to microcephaly and Guillain-Barré syndrome increase linked to Zika.

Multiple arenaviruses, hemorrhagic fevers, zoonotic and other vector-borne viruses or arboviruses have emerged as global public health problems and some of them now seen in regions such as Europe and North America, where people, even asymptomatic, from different countries of Africa, Latin America and Asia, are carriers of the infection. For these reasons, in endemic and non-endemic regions is important to keep in mind and to know about the clinical and epidemiological aspects, as well diagnostic and therapeutic implications of these viral diseases in different contexts, even more in the context of globalization and migration, that now concern not only from middle-east to Europe, but also in Latin America from Venezuela to other countries in the region.

We invite authors to submit original research and review articles that focus on or illuminate aspects of the epidemiology, clinical, diagnostics, therapeutics and prevention of Viral Emerging and Re-emerging Infectious Diseases. We are particularly interested in topics that, further from theoretical/basic science value, have a potential epidemiological and clinical utility. The proposed topics should focus on aspects of diseases such as, but not limited to, infections in pregnancy, animal disease, congenital syndromes, chronic complications, neurological issues, mathematical modelling, travel medicine, vaccines, among others.

Currently open for submissions - please submit here

  1. Since the beginning of the COVID-19 pandemic, therapeutic options for treating COVID-19 have been investigated at different stages of clinical manifestations. Considering the particular impact of COVID-19 in t...

    Authors: Alexandre Naime Barbosa, Alberto Chebabo, Carlos Starling, Clevy Pérez, Clóvis Arns Cunha, David de Luna, Estevão Portela Nunes, Gabriela Zambrano, Juliana Carvalho Ferreira, Julio Croda, Maicon Falavigna, Monica Maria Gomes-da-Silva, Monica Thormann, Sergio Cimerman, Suena Medeiros Parahiba, Suzana Tanni…
    Citation: Annals of Clinical Microbiology and Antimicrobials 2023 22:67
  2. This meta-analysis evaluated the Efficacy and Effectiveness of several COVID-19 vaccines, including AstraZeneca, Pfizer, Moderna, Bharat, and Johnson & Johnson, to better estimate their immunogenicity, benefit...

    Authors: Marzieh Soheili, Sorour Khateri, Farhad Moradpour, Pardis Mohammadzedeh, Mostafa Zareie, Seyede Maryam Mahdavi Mortazavi, Sima Manifar, Hamed Gilzad Kohan and Yousef Moradi
    Citation: Annals of Clinical Microbiology and Antimicrobials 2023 22:42
  3. Curvularia hawaiiensis (formerly Bipolaris hawaiiensis) is a plant pathogen often isolated from soil and vegetative material. However, only a few cases of opportunistic invasive infections in humans have been des...

    Authors: Cristina Aguirre, Jaime David Acosta-España, Sheila Jissela Patajalo-Villata and Alfonso J. Rodriguez-Morales
    Citation: Annals of Clinical Microbiology and Antimicrobials 2023 22:36
  4. A multicountry monkeypox disease (MPX) outbreak began in May 2022 in Europe, leading to the assessment as a potential Public Health Emergency of International Concern (PHEIC) on June 23, 2022. Some observation...

    Authors: Vicente A. Benites-Zapata, Juan R. Ulloque-Badaracco, Esteban A. Alarcon-Braga, Enrique A. Hernandez-Bustamante, Melany D. Mosquera-Rojas, D. Katterine Bonilla-Aldana and Alfonso J. Rodriguez-Morales
    Citation: Annals of Clinical Microbiology and Antimicrobials 2022 21:36
  5. Coronavirus disease 2019 (COVID-19) is the second pandemic of the twenty-first century, with over one-hundred million infections and over two million deaths to date. It is a novel strain from the Coronaviridae fa...

    Authors: Saad I. Mallah, Omar K. Ghorab, Sabrina Al-Salmi, Omar S. Abdellatif, Tharmegan Tharmaratnam, Mina Amin Iskandar, Jessica Atef Nassef Sefen, Pardeep Sidhu, Bassam Atallah, Rania El-Lababidi and Manaf Al-Qahtani
    Citation: Annals of Clinical Microbiology and Antimicrobials 2021 20:35
  6. Lassa fever (LF), a zoonotic illness, represents a public health burden in West African countries where the Lassa virus (LASV) circulates among rodents. Human exposure hinges significantly on LASV ecology, whi...

    Authors: Liã Bárbara Arruda, Najmul Haider, Ayodeji Olayemi, David Simons, Deborah Ehichioya, Adesola Yinka-Ogunleye, Rashid Ansumana, Margaret J. Thomason, Danny Asogun, Chikwe Ihekweazu, Elisabeth Fichet-Calvet and Richard A. Kock
    Citation: Annals of Clinical Microbiology and Antimicrobials 2021 20:29
  7. The Severe Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has gained research attention worldwide, given the current pandemic. Nevertheless, a previous zoonotic and highly pathogenic coronavirus, the Middle E...

    Authors: Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Mohammed A. Alqumber, Shafiul Haque, Shailesh Kumar Patel, Mamta Pathak, Ruchi Tiwari, Mohd. Iqbal Yatoo, Abrar Ul Haq, Muhammad Bilal, Kuldeep Dhama and Alfonso J. Rodriguez-Morales
    Citation: Annals of Clinical Microbiology and Antimicrobials 2021 20:8
  8. Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is an emerging viral pandemic disease. In the last 6 months, SARS-CoV-2 has caused millions of reported cases and hundreds of thousands of deaths. A...

    Authors: Salim Mattar, Caty Martinez-Bravo, Ricardo Rivero, Héctor Contreras, Álvaro A. Faccini-Martínez, Camilo Guzman-Teran, Ketty Galeano, Nelson Alvis-Guzman, Verónica Contreras, German Arrieta, Marco Gonzalez-Tous, Jorge Miranda, Martha Ospina, Francisco Camargo-Assis, Marcela Mercado-Reyes, Evelyn Garay…
    Citation: Annals of Clinical Microbiology and Antimicrobials 2020 19:58
  9. A novel coronavirus (SARS-CoV-2), causing an emerging coronavirus disease (COVID-19), first detected in Wuhan City, Hubei Province, China, which has taken a catastrophic turn with high toll rates in China and ...

    Authors: Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Ruchi Tiwari, Mohd. Iqbal Yatoo, Shailesh Kumar Patel, Mamta Pathak, Yashpal Singh Malik, Kuldeep Dhama, Karam Pal Singh, D. Katterine Bonilla-Aldana, Shafiul Haque, Dayron F. Martinez-Pulgarin, Alfonso J. Rodriguez-Morales and Hakan Leblebicioglu
    Citation: Annals of Clinical Microbiology and Antimicrobials 2020 19:40
  10. Authors: Cecilia Acuti Martellucci, Ranjit Sah, Ali A. Rabaan, Kuldeep Dhama, Cristina Casalone, Kovy Arteaga-Livias, Toyoaki Sawano, Akihiko Ozaki, Divya Bhandari, Asaka Higuchi, Yasuhiro Kotera, Zareena Fathah, Namrata Roy, Mohammed Ateeq Ur Rahman, Tetsuya Tanimoto and Alfonso J. Rodriguez-Morales
    Citation: Annals of Clinical Microbiology and Antimicrobials 2020 19:30
  11. The equine encephalitis viruses, Venezuelan (VEEV), East (EEEV) and West (WEEV), belong to the genus alphavirus, family Togaviridae and still represent a threat for human and animal public health in the Americ...

    Authors: Camilo Guzmán-Terán, Alfonso Calderón-Rangel, Alfonso Rodriguez-Morales and Salim Mattar
    Citation: Annals of Clinical Microbiology and Antimicrobials 2020 19:19
  12. COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents...

    Authors: José Millán-Oñate, William Millan, Luis Alfonso Mendoza, Carlos Guillermo Sánchez, Hugo Fernandez-Suarez, D. Katterine Bonilla-Aldana and Alfonso J. Rodríguez-Morales
    Citation: Annals of Clinical Microbiology and Antimicrobials 2020 19:16
  13. Rift Valley Fever (RVF) is an emerging zoonotic arbovirus with a complex cycle of transmission that makes difficult the prediction of its expansion. Recent outbreaks outside Africa have led to rediscover the h...

    Authors: Emilie Javelle, Alexandre Lesueur, Vincent Pommier de Santi, Franck de Laval, Thibault Lefebvre, Guillaume Holweck, Guillaume André Durand, Isabelle Leparc-Goffart, Gaëtan Texier and Fabrice Simon
    Citation: Annals of Clinical Microbiology and Antimicrobials 2020 19:4
  14. Bats are an important ecological group within ecosystems. The rabies virus is a Lyssavirus, and haematophagous bats are the principal reservoir; however, the virus has also been detected in non-haematophagous bat...

    Authors: Alfonso Calderón, Camilo Guzmán, Salim Mattar, Virginia Rodríguez, Arles Acosta and Caty Martínez
    Citation: Annals of Clinical Microbiology and Antimicrobials 2019 18:11
  15. Considerable progress has been made in dengue management, however the lack of appropriate predictors of severity has led to huge number of unwanted admissions mostly decided on the grounds of warning signs. Ap...

    Authors: Nguyen Thi Ngoc Phuong, Dao Huy Manh, Shyam Prakash Dumre, Shusaku Mizukami, Lan Nguyen Weiss, Nguyen Van Thuong, Tran Thi Ngoc Ha, Le Hong Phuc, Tran Van An, Thuan Minh Tieu, Mohamed Gomaa Kamel, Mostafa Ebraheem Morra, Vu Thi Que Huong, Nguyen Tien Huy and Kenji Hirayama
    Citation: Annals of Clinical Microbiology and Antimicrobials 2019 18:10
  16. The introduction of the dengue virus (DENV) in Nepal is recent, first reports date back to 2004 from a Japanese traveller and limited information is available about DENV infection in the Nepali population. Wit...

    Authors: Birendra Prasad Gupta, Andrea Haselbeck, Jerome H. Kim, Florian Marks and Tarun Saluja
    Citation: Annals of Clinical Microbiology and Antimicrobials 2018 17:32
  17. Dengue is a global health problem and expansion of its endemics towards new territories in the hilly regions in Nepal is a serious concern. It appeared as a new disease in Nepal in 2004 from Japanese traveler ...

    Authors: Birendra Prasad Gupta, Reshma Tuladhar, Roshan Kurmi and Krishna Das Manandhar
    Citation: Annals of Clinical Microbiology and Antimicrobials 2018 17:6